The partnership will leverage artificial intelligence to build a clinical platform using Invitae’s broad genomic data with Allelica’s analytical and predictive software tools.
Researchers have linked broad infection protection from Bacille Calmette-Guérin (BCG) vaccination in newborns to metabolic and lipidomic changes that trigger the immune system.
Using a novel genetic mapping approach, researchers have found links between DNA variations and thousands of blood proteins in people of both European and African ancestry.
Imagene’s technology uses digital pathology images and its proprietary algorithms to identify and classify patterns not discernible by human examination to develop genomic, proteomic and spatial insights of cancer.
Smartphone near-infra red camera can detect pupil size using specially designed app that is being tested as a neurological disease predictor.
Kelonia has launched with $50 million to create an “off-the-shelf” chimeric antigen receptor to treat hematologic cancer.
Scientists knew little about the role played by miR-137 in the brain, but new research in mice, zebrafish, and human cells has demonstrated that it is associated with hypocretin regulation and with sleep.
Four new target molecules of potential significance for future personalized treatment of multiple sclerosis (MS) have been identified by researchers at the Karolinska Institute in Sweden.
The Million Veteran Program data has revealed genetic links between COVID-19 severity and other conditions such as venous embolism and thrombosis, type 2 diabetes, ischemic heart disease, and neutropenia.
Metabolic signatures that discriminate between those with Alzheimer’s disease and cognitively normal individuals have been identified.
